{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:06:13Z","timestamp":1781316373047,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000740","name":"University of St Andrews","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Mo20118\/1"],"award-info":[{"award-number":["MR\/Mo20118\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bmcl.2024.129883","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T19:04:39Z","timestamp":1720983879000},"page":"129883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-3270","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Garsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-3327","authenticated-orcid":false,"given":"Sofiane","family":"Hocine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-1947","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Hensienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Moitessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5287-4488","authenticated-orcid":false,"given":"Louise L.","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-2009","authenticated-orcid":false,"given":"Terry K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-6972","authenticated-orcid":false,"given":"Stephen","family":"Hanessian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129883_b0005","unstructured":"WHO, WHO fact sheet on Leishmaniasis, 12 January 2023."},{"key":"10.1016\/j.bmcl.2024.129883_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24213886","article-title":"Recent advances in the discovery of novel antiprotozoal agents","volume":"24","author":"Lee","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.bmcl.2024.129883_b0015","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human african trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem Rev."},{"key":"10.1016\/j.bmcl.2024.129883_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-3-15","article-title":"The Development of Drugs for Treatment of Sleeping Sickness: A Historical Review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit Vectors."},{"key":"10.1016\/j.bmcl.2024.129883_b0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","article-title":"Drugs and drug resistance in African trypanosomiasis","volume":"10","author":"Delespaux","year":"2007","journal-title":"Drug Resist Updat."},{"key":"10.1016\/j.bmcl.2024.129883_b0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CMR.8.3.427","article-title":"Human antiprotozoal therapy: past, present, and future","volume":"8","author":"Khaw","year":"1995","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.bmcl.2024.129883_b0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1381612023396230","article-title":"Cell biology of Leishmania Spp.: invading and evading","volume":"8","author":"Vannier-Santos","year":"2002","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.bmcl.2024.129883_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/acsinfecdis.7b00187","article-title":"Design and synthesis of broad spectrum trypanosomatid selective inhibitors","volume":"4","author":"Fraser","year":"2018","journal-title":"ACS Infect Dis."},{"key":"10.1016\/j.bmcl.2024.129883_b0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.08.012","article-title":"An update on small molecule strategies targeting leishmaniasis","volume":"157","author":"Kapil","year":"2018","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2024.129883_b0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd1227","article-title":"ACE revisited: a new target for structure-based drug design","volume":"2","author":"Acharya","year":"2003","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.bmcl.2024.129883_b0055","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.03-0093life","article-title":"The discovery of captopril","volume":"17","author":"Smith","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bmcl.2024.129883_b0060","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/bi049480n","article-title":"Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme","volume":"43","author":"Natesh","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2024.129883_b0065","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1111\/j.1742-4658.2011.08276.x","article-title":"Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril","volume":"278","author":"Akif","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bmcl.2024.129883_b0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molbiopara.2005.09.014","article-title":"Cloning and characterization of angiotensin converting enzyme related dipeptidylcarboxypeptidase from leishmania donovani","volume":"145","author":"Goyal","year":"2006","journal-title":"Mol Biochem Parasitol."},{"key":"10.1016\/j.bmcl.2024.129883_b0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10822-009-9315-y","article-title":"Characterization of dipeptidylcarboxypeptidase of leishmania donovani: a molecular model for structure based design of antileishmanials","volume":"24","author":"Baig","year":"2010","journal-title":"J Comput Aided Mol Des."},{"key":"10.1016\/j.bmcl.2024.129883_b0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1747-0285.2011.01262.x","article-title":"Identification of Novel inhibitors of dipeptidylcarboxypeptidase of leishmania donovani via ligand-based virtual screening and biological evaluation","volume":"79","author":"Gangwar","year":"2012","journal-title":"Chem Biol Drug Des."},{"key":"10.1016\/j.bmcl.2024.129883_b0085","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.bmcl.2024.129883_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-3-63","article-title":"Evidence that low endocytic activity is not directly responsible for human serum resistance in the insect form of African trypanosomes","volume":"3","author":"Natesan","year":"2010","journal-title":"BMC Res Notes."},{"key":"10.1016\/j.bmcl.2024.129883_b0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"Hirumi","year":"1989","journal-title":"J Parasitol."},{"key":"10.1016\/j.bmcl.2024.129883_b0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1432-1033.1994.t01-1-01019.x","article-title":"Identification and biosynthesis of N1, N9-Bis(Glutathionyl)Aminopropylcadaverine (Homotrypanothione) in trypanosoma cruzi","volume":"226","author":"Hunter","year":"1994","journal-title":"Eur J Biochem."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24002853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24002853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T03:15:17Z","timestamp":1722050117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24002853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":20,"alternative-id":["S0960894X24002853"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129883","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129883"}}